Angelini Ventures | Activity | F4

Team Portfolio Raise Champions Essays

F4/Angelini Ventures/Activity

Angelini Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

3 investments· AUG 2026 – SEP 2026Show all

Investment

Aptadir closed a EUR 40M seed round to advance RNA therapeutics for Fragile X syndrome.

Aptadir Therapeutics

Aptadir Therapeutics Angelini Ventures

angeliniventures.comSEP 29, 2026

SEP 29, 2026

Investment

Invested EUR 17M with the European Investment Bank in MMI, advancing robotic microsurgery.

MMI

MMI Angelini Ventures

angeliniventures.comSEP 16, 2026

finance.yahoo.com

SEP 16, 2026

Investment

Invested in Epicrispr's USD 90M Series C for an epigenetic therapy for FSHD.

Epicrispr Biotechnologies

Epicrispr Biotechnologies Angelini Ventures

angeliniventures.comAUG 10, 2026

AUG 10, 2026